Magazine articles list

"Moving schools turned out to be a great decision"

Ruby Abramow was first diagnosed with a rare head and neck cancer aged nine, before relapsing in 2019, when she was 14. Now 19, she tells us how a new, supportive environment gave her the fresh start she needed to take back control of her disrupted education.

Education after a childhood cancer diagnosis

Parents and carers of children who have been diagnosed with cancer often have many questions about school and education. Keeley McEvoy, Lead Assistant Headteacher of the Medical Needs Teaching Service working at Leeds Children’s Hospital, explains more about what to expect from hospital teaching, ongoing education support and transitioning back to school.

Why working together is so important

Naomi Duxbury’s daughter, Mia, was aged four when diagnosed with B-cell acute lymphoblastic leukaemia in September 2021. Here, she tells us about the importance of working closely with Mia’s school to create a safe, supportive and ‘normal’ learning environment for her.

A parent's view... Facing challenges with the education system

Lauren Bryce’s son, Alfie, had just begun his final year of school when he was diagnosed with leukaemia, aged 15. Here, she tells us about their struggles with the education system after his diagnosis and what could have helped him as he prepared to take his GCSEs.

How schools can adapt to flexible learning

Sophie Barclay was 15 when diagnosed with a brain tumour, making schooling and exams difficult. Now 18, she tells us how, with the support of her school, she has received a conditional offer for university.

Molecular radiotherapy for children’s cancers

Molecular radiotherapy (MRT) is an evolving form of children’s cancer treatment. Dr Mark Gaze, Caroline Elmagrahi and Georgia Azzopardi, of University College London Hospitals NHS Foundation Trust, tell us more about what it is and what work is being done to develop its usage.

Harnessing artificial intelligence to identify new drug combinations

Artificial intelligence (AI) has helped scientists propose a promising new drug combination for DIPG brain tumours. Prof Chris Jones, Director of the Brain Tumour Research Centre of Excellence at the Institute of Cancer Research (ICR), and Dr Fernando Carceller, Paediatric Neuro-Oncology Consultant at The Royal Marsden Hospital, tell us more.

How is ambulatory care improving young people’s experiences of treatment?

Dr Alison Finch is a nurse and researcher from University College London Hospitals NHS Foundation Trust (UCLH). She explains how ambulatory care is positively impacting young people’s experiences of treatment and how a CCLG Special Interest Group has been formed to develop this care nationally.